HAT₂CH₂ score performance predicting neurologic events after cardiac implantable electronic device.

ABSTRACT: Objectives: The HAT₂CH₂ score has been evaluated for predicting new-onset atrial fibrillation in several clinical conditions, but never for adverse neurologic events. We aimed to evaluate the effectiveness of HAT₂CH₂ score in predicting neurologic events in patients with cardiac implantable electronic device (CIED), comparing with atrial high-rate episodes (AHRE). Methods: This case-control study enrolled 314 consecutive patients aged 18 years or older with CIED implantation between January 2015 and April 2021. Patient data were analyzed retrospectively. The primary endpoint was subsequent neurologic events (NE) after implantation. AHRE was defined as > 175 bpm (Medtronic®) lasting ≥ 30 seconds. Variables associated with independent

SUBMITTER: Chen JY 

PROVIDER: S-EPMC9149640 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature